DE69232969D1 - Methode zur herstellung von gram-negativen bakteriellen vakzinen - Google Patents

Methode zur herstellung von gram-negativen bakteriellen vakzinen

Info

Publication number
DE69232969D1
DE69232969D1 DE69232969T DE69232969T DE69232969D1 DE 69232969 D1 DE69232969 D1 DE 69232969D1 DE 69232969 T DE69232969 T DE 69232969T DE 69232969 T DE69232969 T DE 69232969T DE 69232969 D1 DE69232969 D1 DE 69232969D1
Authority
DE
Germany
Prior art keywords
vaccine
negative bacterial
gram
pct
mineral carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69232969T
Other languages
English (en)
Other versions
DE69232969T2 (de
Inventor
A Dearwester
S Roberts
A Swearingin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69232969D1 publication Critical patent/DE69232969D1/de
Publication of DE69232969T2 publication Critical patent/DE69232969T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69232969T 1991-11-15 1992-11-13 Methode zur herstellung von gram-negativen bakteriellen vakzinen Expired - Lifetime DE69232969T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79248891A 1991-11-15 1991-11-15
US792488 1991-11-15
PCT/US1992/009944 WO1993010216A1 (en) 1991-11-15 1992-11-13 Gram-negative bacterial vaccines

Publications (2)

Publication Number Publication Date
DE69232969D1 true DE69232969D1 (de) 2003-04-24
DE69232969T2 DE69232969T2 (de) 2004-08-05

Family

ID=25157051

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232969T Expired - Lifetime DE69232969T2 (de) 1991-11-15 1992-11-13 Methode zur herstellung von gram-negativen bakteriellen vakzinen

Country Status (10)

Country Link
US (1) US5616328A (de)
EP (1) EP0669971B1 (de)
JP (1) JP3043809B2 (de)
AT (1) ATE234916T1 (de)
AU (1) AU667858B2 (de)
CA (1) CA2123222C (de)
DE (1) DE69232969T2 (de)
DK (1) DK0669971T3 (de)
ES (1) ES2194841T3 (de)
WO (1) WO1993010216A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2188424A1 (en) * 1994-04-28 1995-11-09 Akihiro Suehara Method of separating protective components of bordetella pertussis
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US6749831B1 (en) 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
US6713071B1 (en) * 1998-10-22 2004-03-30 Pfizer Inc. Proteins from actinobacillus pleuropneumoniae
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
CA2290078C (en) * 1999-01-29 2013-01-22 Pfizer Products Inc. Erysipelothrix rhusiopathiae antigens and vaccine compositions
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
US6765372B2 (en) 2001-12-14 2004-07-20 Intersil Americas Inc. Programmable current-sensing circuit providing continuous temperature compensation for DC-DC Converter
AU2003289398A1 (en) * 2002-12-18 2004-07-09 Techno Network Shikoku Co., Ltd. Vaccine for fish cold-water disease
US7521059B2 (en) * 2004-06-14 2009-04-21 Fenwick Bradley W Kennel cough vaccine
WO2006029223A2 (en) * 2004-09-08 2006-03-16 Children's Medical Center Corporation Method for stimulating the immune response of newborns
US9481724B2 (en) 2011-12-19 2016-11-01 The Rockefeller University hDC-sign binding peptides
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
WO2022114921A1 (ko) * 2020-11-30 2022-06-02 주식회사 엘지화학 알루미늄 부형제를 이용하여 다가 혼합백신 내 백일해 균 유래 엔도톡신 제거 방법
CN113670914B (zh) * 2021-08-19 2024-03-08 青岛易邦生物工程有限公司 一种油乳剂灭活疫苗的细菌内毒素检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
US4465665A (en) * 1982-03-04 1984-08-14 Smithkline-Rit Detoxified E. coli neurotoxin, preparation thereof and immunological preparations containing it
US4705686A (en) * 1986-05-09 1987-11-10 American Cyanamid Process for the preparation of acellular Bordetalla pertussis vaccine
US4789544A (en) * 1986-05-23 1988-12-06 Midcon Labs. Inc. Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation
US5019388A (en) * 1986-10-14 1991-05-28 Norden Laboratories Inc. Bordetella bronchiseptica vaccine
US5101019A (en) * 1987-05-22 1992-03-31 Takeda Chemical Industries, Ltd. Method for removing pertussis endotoxin, a pertussis toxoid and its production
ATE183202T1 (de) * 1990-06-13 1999-08-15 Pfizer Pasteurella multocida toxoid enthaltende impfstoffe

Also Published As

Publication number Publication date
DE69232969T2 (de) 2004-08-05
AU3141393A (en) 1993-06-15
JP3043809B2 (ja) 2000-05-22
DK0669971T3 (da) 2003-04-22
CA2123222A1 (en) 1993-05-27
EP0669971A4 (de) 1995-04-19
ATE234916T1 (de) 2003-04-15
US5616328A (en) 1997-04-01
EP0669971B1 (de) 2003-03-19
ES2194841T3 (es) 2003-12-01
EP0669971A1 (de) 1995-09-06
JPH07501333A (ja) 1995-02-09
WO1993010216A1 (en) 1993-05-27
AU667858B2 (en) 1996-04-18
CA2123222C (en) 2001-02-27

Similar Documents

Publication Publication Date Title
ATE234916T1 (de) Methode zur herstellung von gram-negativen bakteriellen vakzinen
IL138798A0 (en) Vaccines and antibodies against bacterial pneumococcal infection
DE69734601D1 (de) Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen
ES500567A0 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
EP0749321A4 (de) Aktive immunisierung gegen ein siderophores rezeptorprotein
CA2231603A1 (en) Chicken interleukin-15 and uses thereof
CA2022420A1 (en) Escherichia coli vaccine
AU7763294A (en) Live in ovo vaccine
BR9713312B1 (pt) preparado de vacina para uso veterinário útil para produzir imunidade ativa contra uma doença bacteriana ou protozoária.
Yang et al. Specific humoral immune response induced by propionibacterium acnes can prevent Actinobacillus pleuropneumoniae infection in mice
DE69527986D1 (de) Antigene arznei zur behandlung oder vorbeugung
ES8802117A1 (es) Un metodo para preparar una vacuna para inmunizacion contra enfermedades por bacterias gram-negativas
ATE356633T1 (de) Vakzin für einen nicht typisierbaren haemophilus influenzae stamm
NL300121I2 (nl) Nieuwe bacterie die een pluimveeziekte veroorzaakten een daarvan afgeleid vaccin.
AU673344B2 (en) Vaccines based on streptokinase
ATE258445T1 (de) Impfstoff beinhaltend bacterin und toxoid aus pasteurella haemolytica typ a-1
DE59708140D1 (de) Verwendung eines immunglobulinpräparates zur herstellung eines oral anzuwendenden medikaments zur prävention des hämolytischen urämischen syndroms sowie präparat hierfür
IL122829A0 (en) Isolated strains of staphylococcus aureus and vaccines manufactured therefrom
DE69208854D1 (de) Impfstoff-Zubereitung zur Vorbeugung gegen bei Tieren durch Chlamydia psitacci verursachte Fehlgeburt

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 669971

Country of ref document: EP